Procedure
Combined strategy
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Other(2)
Detailed Status
unknown2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
not_yet_recruiting133%
unknown267%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable
Combined Strategy Using Automated Subglottic Secretion Drainage and Continuous Cuff Pressure Monitoring to Prevent Microaspiration: a Multicenter Randomized Controlled Trial.
NCT07555236
unknownnot_applicable
Urinary Parameters to Predict Weaning of Renal Replacement Therapy in the Critically Ill
NCT06214390
unknownnot_applicable
Effectiveness of a Combined Strategy to Improve Therapeutic Compliance and Degree of Control Among Patients With Hypercholesterolaemia
NCT02314663
Clinical Trials (3)
Showing 3 of 3 trials
NCT07555236Not Applicable
Combined Strategy Using Automated Subglottic Secretion Drainage and Continuous Cuff Pressure Monitoring to Prevent Microaspiration: a Multicenter Randomized Controlled Trial.
NCT06214390Not Applicable
Urinary Parameters to Predict Weaning of Renal Replacement Therapy in the Critically Ill
NCT02314663Not Applicable
Effectiveness of a Combined Strategy to Improve Therapeutic Compliance and Degree of Control Among Patients With Hypercholesterolaemia
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3